Exceptional Ventures is an early-stage Venture Capital firm based in London that invests in high-impact businesses focused on helping people live happier, healthier, and longer lives, while championing a sustainable planet.
Portfolio
11
companies
Clerkenwell Health
Clerkenwell Health operates a specialist clinical research facility for psychedelic assisted therapies.
Evaro
Evaro operates a healthcare-as-a-service platform for consumer applications.
Gladys
Gladys provides an artificial intelligence platform to connect families with local care workers.
Gradient Labs
Gradient Labs builds artificial intelligence agents for automated financial operations.
Jove
Jove provides digital insurance and compliance platforms for contractors and small businesses.
Net Purpose
Net Purpose builds an independent fact base of social and environmental performance for sustainable investors.
PreActiv
PreActiv provides a digital platform that delivers tailored prehabilitation programmes for surgical patients.
Punto Health
Punto Health develops an artificial intelligence powered platform for dementia and cognitive care.
Rest Less
Rest Less is a digital community and financial services platform for people over 50.
SAVA
SAVA develops pain-free real-time microsensors for health monitoring.
Unfabled
Unfabled is a women's health platform offering supplements designed for female wellness.
Matt Cooper
Chairman
Michella Botto
Investment Manager
Paolo Pio
Co-Founder and General Partner
Octopus Ventures and CommerzVentures joined the round to support international expansion and product development.
"What we’re building is the agent layer that financial services need to run their customer operations autonomously. It has to work the way they do, connect to the systems they have already built, and handle the long-running work that has stayed manual until now"
AlbionVC led the Series A round for the healthcare-as-a-service provider, with backing from Simplyhealth Ventures, Exceptional Ventures, Cornerstone VC, and BBI.
The seed round was co-led by Shilling and Plus Partners to accelerate commercial expansion across the UK and Spain.
"Dementia is never just one person’s disease. It affects entire families, and carers often carry an enormous invisible burden."
The financing round was led by Cornerstone with backing from several early stage investors.
"Rising care costs, an overstretched social care system, and the demands of daily life can leave families feeling guilty and stretched thin as they think about their elderly loved ones. That’s why I’m thrilled to back George and Alex as they build Gladys, a managed social care platform that makes it easy to find and book trusted caregivers and companions. Their mission is close to my heart: giving families peace of mind and helping everyone grow old with dignity, in the home they cherish, for as long as possible."
The London healthtech startup secured backing from Balderton and Pentland to scale manufacturing and regulatory pathways for its continuous glucose monitor.
"During their time at Imperial, they worked in one of the pioneering research groups that invented modern glucose strip technology. Their combined expertise in electrochemistry, biosensing, and medical device engineering laid the foundation for Sava’s next-generation biosensor platform."
